Published in PLoS Pathog on May 27, 2010
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis (2012) 2.72
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood (2014) 2.04
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection. Genome Med (2016) 1.47
Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model. PLoS One (2015) 1.41
Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells. J Immunol (2013) 1.28
Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis (2013) 1.27
Cellular signaling and biological functions of R-spondins. Cell Signal (2011) 1.25
The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis (2013) 1.01
Emerging evidence on the pathobiology of mucositis. Support Care Cancer (2013) 0.99
Emerging evidence on the pathobiology of mucositis. Support Care Cancer (2013) 0.97
Microbiome mediation of infections in the cancer setting. Genome Med (2016) 0.94
The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life. BMC Cancer (2014) 0.91
Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death Differ (2014) 0.90
Enterocytes' tight junctions: From molecules to diseases. World J Gastrointest Pathophysiol (2011) 0.89
Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PLoS One (2012) 0.88
TLR signaling modulates side effects of anticancer therapy in the small intestine. J Immunol (2015) 0.86
Evidence for bistable bacteria-neutrophil interaction and its clinical implications. J Clin Invest (2012) 0.86
Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis. BMC Genomics (2016) 0.85
Enteral tube feeding alters the oral indigenous microbiota in elderly adults. Appl Environ Microbiol (2011) 0.84
Molecular identification of bacteria in tracheal aspirate fluid from mechanically ventilated preterm infants. PLoS One (2011) 0.83
The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma. EBioMedicine (2017) 0.83
Risk factors associated with Clostridium difficile infection in adult oncology patients. Support Care Cancer (2014) 0.83
Intestinal microbiome changes and stem cell transplantation: Lessons learned. Virulence (2016) 0.82
Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective study. Clin Microbiol Infect (2013) 0.82
Gut microbiota and hematopoietic stem cell transplantation: where do we stand? Bone Marrow Transplant (2016) 0.81
Impact of space flight on bacterial virulence and antibiotic susceptibility. Infect Drug Resist (2015) 0.81
New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol (2011) 0.81
Interaction between host cells and microbes in chemotherapy-induced mucositis. Nutrients (2013) 0.81
Host-Microbiome Cross-talk in Oral Mucositis. J Dent Res (2016) 0.81
Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support Care Cancer (2014) 0.80
16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation. Microb Ecol (2014) 0.80
The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis. PLoS One (2015) 0.79
Mucin-Microbiota Interaction During Postnatal Maturation of the Intestinal Ecosystem: Clinical Implications. Dig Dis Sci (2016) 0.78
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments. Front Pharmacol (2016) 0.78
Tumor grafting induces changes of gut microbiota in athymic nude mice in the presence and absence of medicinal Gynostemma saponins. PLoS One (2015) 0.77
Intestinal microbiota and anastomotic leakage of stapled colorectal anastomoses: a pilot study. Surg Endosc (2015) 0.77
How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions. Pathogens (2016) 0.77
Protective effect of curcumin on chemotherapy-induced intestinal dysfunction. Int J Clin Exp Pathol (2013) 0.77
Why should we need the gut microbiota to respond to cancer therapies? Oncoimmunology (2014) 0.76
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. J Transl Med (2014) 0.76
Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants. PLoS One (2017) 0.76
New Insights into the Enterococcus faecium and Streptococcus gallolyticus subsp. gallolyticus Host Interaction Mechanisms. PLoS One (2016) 0.75
Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2016) 0.75
The effect of hydrolysates of proteins from rice milk on the physiological response of enterocytes and on the adhesion of bacteria from healthy and allergic people - an in vitro study. Cent Eur J Immunol (2017) 0.75
Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. F1000Res (2017) 0.75
Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function. Cell Mol Gastroenterol Hepatol (2017) 0.75
Ganoderma lucidum polysaccharides reduce methotrexate-induced small intestinal damage in mice via induction of epithelial cell proliferation and migration. Acta Pharmacol Sin (2011) 0.75
Bacteriophages as potential new mammalian pathogens. Sci Rep (2017) 0.75
Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats. Cancer Chemother Pharmacol (2017) 0.75
The influence of neoadjuvant chemotherapy on gastric cancer patients' postoperative infectious complications: What is the negative role played by the intestinal barrier dysfunction? Oncotarget (2017) 0.75
A childhood-onset intestinal toxemia botulism during chemotherapy for relapsed acute leukemia. Ann Clin Microbiol Antimicrob (2017) 0.75
The Role of Microbiota and Immunobiotics in Granulopoiesis of Immunocompromised Hosts. Front Immunol (2017) 0.75
Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One (2017) 0.75
Biomarkers and non-invasive tests for gastrointestinal mucositis. Support Care Cancer (2017) 0.75
Curcuminoids from Curcuma longaL. reduced intestinal mucositis induced by 5-fluorouracil in mice: Bioadhesive, proliferative, anti-inflammatory and antioxidant effects. Toxicol Rep (2015) 0.75
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Commensal host-bacterial relationships in the gut. Science (2001) 14.82
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Recognition of microorganisms and activation of the immune response. Nature (2007) 12.99
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
Concern Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.70
Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (2006) 9.95
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol (2000) 8.13
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A (2008) 7.43
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol (2000) 6.62
Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology (2006) 6.55
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology (2004) 6.47
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol (2003) 5.87
Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther (2007) 5.47
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol (2005) 4.28
Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology (2006) 3.96
Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med (1989) 3.92
The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol (2001) 3.53
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest (2005) 3.36
Barrier function of epithelia. Am J Physiol (1981) 3.21
Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev (2009) 3.20
Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol (2005) 3.00
Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol (2006) 3.00
The pathobiology of mucositis. Nat Rev Cancer (2004) 2.99
Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol (2002) 2.35
Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology (2004) 2.33
Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol (2003) 2.30
Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis (2005) 2.21
Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology (2002) 2.19
Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity (2006) 2.06
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol (2001) 2.05
Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut (2003) 2.00
Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol (2008) 1.99
Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. Typhimurium colitis. J Exp Med (2008) 1.92
Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect Immun (2006) 1.87
Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut (2005) 1.84
Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut (2006) 1.81
Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology (2006) 1.73
Exacerbation of intestinal permeability in rats after a two-hit injury: burn and Enterococcus faecalis infection. Crit Care Med (2004) 1.66
Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis (2007) 1.57
The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol (2006) 1.51
Patient reports of complications of bone marrow transplantation. Support Care Cancer (2000) 1.36
Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci (2005) 1.35
The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma (2006) 1.29
Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72. Am J Physiol Gastrointest Liver Physiol (2004) 1.25
The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am J Clin Nutr (2003) 1.23
Transit time of epithelial cells in the small intestines of germfree mice and ex-germfree mice associated with indigenous microorganisms. Appl Environ Microbiol (1981) 1.23
Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr (2008) 1.23
Mucin and Toll-like receptors in host defense against intestinal parasites. Trends Parasitol (2003) 1.20
Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut (2000) 1.18
Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int (2002) 1.15
Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis (2009) 1.14
Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer (2005) 1.14
Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr (2007) 1.13
Safety of probiotics: translocation and infection. Nutr Rev (2008) 1.13
The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol (2008) 1.11
Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. Exp Anim (1996) 1.11
Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther (2005) 1.10
Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB. Am J Physiol Gastrointest Liver Physiol (2003) 1.09
Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J Antimicrob Chemother (2000) 1.09
The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev (2007) 1.09
Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant (2000) 1.08
Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis. Exp Biol Med (Maywood) (2009) 1.07
Dendritic cells in the recognition of intestinal microbiota. Cell Microbiol (2006) 1.03
Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant (2005) 0.98
Immunology. Unraveling gut inflammation. Science (2006) 0.98
Identification of a novel negative role of flagellin in regulating IL-10 production. Eur J Immunol (2007) 0.97
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum (2004) 0.97
Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm Bowel Dis (2007) 0.97
Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J Microbiol Biotechnol (2008) 0.96
Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol (2007) 0.95
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2008) 0.95
The relationship between microbiota and polyamine concentration in the human intestine: a pilot study. Microbiol Immunol (2007) 0.94
Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes. J Cell Physiol (2006) 0.91
Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol (2009) 0.91
Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword. Inflamm Bowel Dis (2008) 0.90
Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin's disease. Int J STD AIDS (2006) 0.90
Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats. Nutrition (2008) 0.90
Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. World J Gastroenterol (2005) 0.89
Regulation of tight junction assembly and epithelial morphogenesis by the heat shock protein Apg-2. BMC Cell Biol (2007) 0.89
Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis. Eur J Clin Nutr (2007) 0.88
Butyrate strongly inhibits in vitro stimulated release of cytokines in blood. Dig Dis Sci (2002) 0.86
Oral administration of short-chain fatty acids reduces the intestinal mucositis caused by treatment with Ara-C in mice fed commercial or elemental diets. Nutr Cancer (1997) 0.86
ComPPARtmentalizing NF-kappaB in the gut. Nat Immunol (2004) 0.84
Acute stress-induced colonic tissue HSP70 expression requires commensal bacterial components and intrinsic glucocorticoid. Brain Behav Immun (2008) 0.82
The influence of the gut microflora and of dietary fibre on epithelial cell migration in the chick intestine. Br J Nutr (1978) 0.82
Influence of colostomy on in vivo and in vitro permeability of the rat colon. Dis Colon Rectum (1996) 0.82
Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo. J Immunol (2008) 0.81
Effects of specific lactic acid bacteria on the intestinal permeability to macromolecules and the inflammatory condition. Acta Paediatr Suppl (2005) 0.78
Butyrate hastens restoration of barrier function after thermal and detergent injury to rat distal colon in vitro. Scand J Gastroenterol (1999) 0.78
Comparison of DNA renewal in germ-free and conventional mice using [125I]iododeoxyuridine and [3H]thymidine. Cell Tissue Kinet (1980) 0.78
Administration of Lactobacillus plantarum 299v reduces side-effects of external radiation on colon anastomotic healing in an experimental model. Colorectal Dis (2001) 0.76
Evidence based selection of housekeeping genes. PLoS One (2007) 7.90
Oral biofilm architecture on natural teeth. PLoS One (2010) 2.78
Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology (2002) 2.71
Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol (2002) 2.35
Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes. Appl Environ Microbiol (2002) 1.82
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia. Blood (2014) 1.80
Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system. Appl Environ Microbiol (2003) 1.74
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine. Blood (2010) 1.62
Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol (2005) 1.62
Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients. Pediatr Blood Cancer (2009) 1.62
Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol (2011) 1.60
PTK787/ZK 222584 inhibits tumor growth promoting mesenchymal stem cells: kinase activity profiling as powerful tool in functional studies. Cancer Biol Ther (2009) 1.45
The Bt-DUX: development of a subjective measure of health-related quality of life in patients who underwent surgery for lower extremity malignant bone tumor. Pediatr Blood Cancer (2009) 1.42
Kinome profiling in pediatric brain tumors as a new approach for target discovery. Cancer Res (2009) 1.40
Tumor vessel biology in pediatric intracranial ependymoma. J Neurosurg Pediatr (2010) 1.38
Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol (2006) 1.38
Genogrouping and incidence of virulence factors of Enterococcus faecalis in liver transplant patients differ from blood culture and fecal isolates. J Infect Dis (2002) 1.33
The species composition of the human intestinal microbiota differs between particle-associated and liquid phase communities. Environ Microbiol (2008) 1.28
Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications. J Clin Oncol (2011) 1.28
Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood (2008) 1.28
Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr (2010) 1.27
Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation? Cancer Treat Rev (2004) 1.25
The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases. ISME J (2012) 1.24
Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit Rev Oncol Hematol (2009) 1.21
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer (2012) 1.17
Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis (2009) 1.14
Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia (2014) 1.12
Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice. Eur J Cancer (2013) 1.09
Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples. J Med Microbiol (2005) 1.08
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia. Haematologica (2010) 1.02
Bacterial pleomorphism and competition in a relative humidity gradient. Environ Microbiol (2008) 1.02
Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat Commun (2013) 1.01
High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia. Blood (2010) 1.01
The first true obligately syntrophic propionate-oxidizing bacterium, Pelotomaculum schinkii sp. nov., co-cultured with Methanospirillum hungatei, and emended description of the genus Pelotomaculum. Int J Syst Evol Microbiol (2005) 1.01
The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme. J Neurosurg (2009) 1.00
Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis (2005) 0.99
Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis. Blood (2003) 0.97
Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia. Clin Pharmacol Ther (2004) 0.97
AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance. Blood (2009) 0.94
Vascular endothelial growth factor signaling in acute myeloid leukemia. Cell Mol Life Sci (2012) 0.93
Enterococcus faecalis surface proteins determine its adhesion mechanism to bile drain materials. Microbiology (2002) 0.93
Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med (2003) 0.92
Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia. Haematologica (2005) 0.92
Risk assessment in fever and neutropenia in children with cancer: What did we learn? Crit Rev Oncol Hematol (2009) 0.92
The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer (2010) 0.91
A new perspective on transcriptional system regulation (TSR): towards TSR profiling. PLoS One (2008) 0.91
Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol (2003) 0.90
The role of breast cancer resistance protein in acute lymphoblastic leukemia. Clin Cancer Res (2003) 0.90
VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms. Eur J Cancer (2010) 0.89
Endothelial damage in long-term survivors of childhood cancer. J Clin Oncol (2013) 0.89
Quality of life in young patients after bone tumor surgery around the knee joint and comparison with healthy controls. Pediatr Blood Cancer (2010) 0.88
Colonic fermentation may play a role in lactose intolerance in humans. J Nutr (2006) 0.88
Microbial growth on the edge of desiccation. Environ Microbiol (2011) 0.88
Identification of new possible targets for leukemia treatment by kinase activity profiling. Leuk Lymphoma (2010) 0.88
Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clin Cancer Res (2005) 0.87
Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high? Eur J Cancer (2007) 0.87
EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion. Neuro Oncol (2012) 0.87
Atomic force microscopy study on specificity and non-specificity of interaction forces between Enterococcus faecalis cells with and without aggregation substance. Microbiology (2005) 0.87
Rationalizing the approach to children with fever in neutropenia. Curr Opin Infect Dis (2012) 0.86
Lactobacilli: important in biofilm formation on voice prostheses. Otolaryngol Head Neck Surg (2007) 0.86
Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD. Haematologica (2011) 0.85
Denaturing gradient gel electrophoresis as a diagnostic tool in periodontal microbiology. J Clin Microbiol (2006) 0.85
Paradoxical down-regulation of p16 mRNA with advancing age in acute myeloid leukemia. Aging (Albany NY) (2009) 0.85
Mesenchymal stem cells contribute to tumor cell proliferation by direct cell-cell contact interactions. Cancer Invest (2010) 0.84
Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care? Pediatr Blood Cancer (2005) 0.84
How can Faecalibacterium prausnitzii employ riboflavin for extracellular electron transfer? Antioxid Redox Signal (2012) 0.84
Adhesion to bile drain materials and physicochemical surface properties of Enterococcus faecalis strains grown in the presence of bile. Appl Environ Microbiol (2002) 0.84
Optimizing targeted cancer therapy: towards clinical application of systems biology approaches. Crit Rev Oncol Hematol (2012) 0.84
The diagnostic value of interleukin-8 for the detection of bacteremia in pediatric hematopoietic stem cell recipients with febrile neutropenia. Transplantation (2014) 0.83
Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategies. Crit Rev Oncol Hematol (2002) 0.83
Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia. J Clin Oncol (2011) 0.83
High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children. Leuk Lymphoma (2003) 0.83
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23). Blood (2010) 0.83
Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns. Support Care Cancer (2013) 0.83
Survival trends and long-term toxicity in pediatric patients with osteosarcoma. Sarcoma (2012) 0.82
Psychometric qualities of the Dutch version of the Pediatric Inventory for Parents (PIP): a multi-center study. Psychooncology (2010) 0.82
Kinase activity profiling reveals active signal transduction pathways in pediatric acute lymphoblastic leukemia: a new approach for target discovery. Proteomics (2015) 0.81
The role of colonic microbiota in lactose intolerance. Dig Dis Sci (2004) 0.81
Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults. Cancer (2003) 0.81
Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma. Pharmacogenet Genomics (2016) 0.81
Topography of distinct Staphylococcus aureus types in chronic wounds of patients with epidermolysis bullosa. PLoS One (2013) 0.81
Reduced absorption of long-chain fatty acids during methotrexate-induced gastrointestinal mucositis in the rat. Clin Nutr (2012) 0.80
Dispositional optimism in adolescents with cancer: differential associations of optimism and pessimism with positive and negative aspects of well-being. Br J Health Psychol (2012) 0.80
Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia. Clin Cancer Res (2008) 0.80
Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support Care Cancer (2014) 0.80
Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death. Anticancer Drugs (2008) 0.80
MBL2 and fever during neutropenia in children with acute lymphoblastic leukaemia. Br J Haematol (2011) 0.79
Providing care to a child with cancer: a longitudinal study on the course, predictors, and impact of caregiving stress during the first year after diagnosis. Psychooncology (2014) 0.79
Continuous enteral administration can enable normal amino acid absorption in rats with methotrexate-induced gastrointestinal mucositis. J Nutr (2012) 0.79
Cytokine production induced by non-encapsulated and encapsulated Porphyromonas gingivalis strains. Arch Oral Biol (2012) 0.79
Long-term cardiac abnormalities after cranial radiotherapy in childhood cancer survivors. Acta Oncol (2014) 0.78